LPCN: Liver Biopsy Results
By John Vandermosten, CFA
NASDAQ:LPCN
READ THE FULL LPCN RESEARCH REPORT
UCL: Chip Shortages and Delays Cause Educational Tablet Order Fulfillment to Slip into 2022
By Lisa Thompson
NASDAQ:UCL
READ THE FULL UCL RESEARCH REPORT
ABVC: Company Continues to Advance Lead Assets & Earlier Stage Candidates
By M. Marin
NASDAQ:ABVC
READ THE FULL ABVC RESEARCH REPORT
CXW: 2Q21 Underscores Recent Balance Sheet Improvements & Strong FFO
By M. Marin
NYSE:CXW
READ THE FULL CXW RESEARCH REPORT
RVPH: Second Quarter Update
By John Vandermosten, CFA
NASDAQ:RVPH
READ THE FULL RVPH RESEARCH REPORT
POETF: POET Will Demo Its New Products at the China International Optoelectronics Show
By Lisa Thompson
OTC:POETF | TSX:PTK.V
NVNXF: Strategic Phillips 66 Relationship Validates & Enhances Prospects
By M. Marin
OTC:NVNXF
READ THE FULL NVNXF RESEARCH REPORT
EPIX: Unwarranted Selloff Following Phase 1 Trial Update
By David Bautz, PhD
NASDAQ:EPIX
READ THE FULL EPIX RESEARCH REPORT